Bimonthly Survey

Please indicate if you have used resources and/or trainings from any of the following in the past 12 months.
Select all that apply
Are you familiar with the AETC Program HIV Care Tools App?

Description

Image
image

Join the Midwest AETC for this webinar on transforming HIV prevention.

Objectives

  • Describe HIV prevention options, including currently approved oral and injectable PrEP options.
  • Explain the mechanism of action, pharmacokinetics, dosing, safety, and efficacy of cabotegravir and lenacapavir for PrEP.
  • Compare the advantages and limitations of long-acting, injectable PrEP.
  • Discuss the HIV PrEP pipeline, including longer-acting agents and novel delivery systems.

Speaker

Emily Drwiega, PharmD, BCIDP, BCPS, AAHIVP
Visiting Clinical Assistant Professor/Clinical Pharmacist
UIC College of Pharmacy